Pyxis Oncology (PYXS) Free Cash Flow (QoQ) (2021 - 2025)
Pyxis Oncology (PYXS) Free Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Pyxis Oncology | 178.35 Mn | 111.49 Mn | 8.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.47% |
| Sep 30, 2025 | 23.09% |
| Jun 30, 2025 | 23.39% |
| Mar 31, 2025 | -16.82% |
| Dec 31, 2024 | -31.54% |
| Sep 30, 2024 | -387.70% |
| Jun 30, 2024 | 85.64% |
| Mar 31, 2024 | -138.98% |
| Dec 31, 2023 | 50.32% |
| Sep 30, 2023 | -14.31% |
| Jun 30, 2023 | 46.96% |
| Mar 31, 2023 | -29.77% |
| Dec 31, 2022 | -3.62% |
| Sep 30, 2022 | 8.48% |
| Jun 30, 2022 | 15.60% |
| Mar 31, 2022 | -130.25% |
| Dec 31, 2021 | -66.97% |
| Sep 30, 2021 | -392.57% |
| Jun 30, 2021 | 113.18% |
| Mar 31, 2021 | -496.78% |